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Abstract
Background: The human TAR RNA-binding protein, TRBP, was first identified and cloned based on its high affinity
binding to the small hairpin trans-activation responsive (TAR) RNA of HIV-1. TRBP has more recently been found to
be a constituent of the RNA-induced silencing complex (RISC) serving as a Dicer co-factor in the processing of the
~70 nucleotide pre-microRNAs(miRNAs) to 21-25 nucleotide mature miRNAs.
Findings: Using co-immunoprecipitation and protein-identification by mass spectrometry, we characterized
intracellular proteins that complex with TRBP. These interacting proteins include those that have been described to
act in protein synthesis, RNA modifications and processing, DNA transcription, and cell proliferation.
Conclusions: Our findings provide a proteome of factors that may cooperate with TRBP in activities such as
miRNA processing and in RNA interference by the RISC complex.
Findings
MicroRNAs (miRNAs) are important regulators of cellu-
lar development, differentiation, proliferation, apoptosis,
metabolism, and oncogenesis [1-4]. Cellular miRNAs
have also been proposed to function in restricting virus
infection of cells [5-11]. The biogenesis of miRNAs in
eukaryotic cells has been reviewed extensively elsewhere
[12,13]. In brief, RNA polymerase II transcribed primary
microRNA transcripts (pri-miRNA) are processed by
Drosha in the nucleus to pre-miRNA precursors which
are then processed by Dicer in the cytoplasm to mature
miRNAs. In analyzing miRNA processing, it was noted
that a cellular protein, TAR RNA-binding protein TRBP,
binds directly to Dicer [14-17] and is important to the
activity of miRNA-mediated RNA-silencing. Moreover, a
TRBP-Ago2 composed RNA-induced silencing complex
(RISC) has been shown to be needed for optimal
miRNA-guided post-transcriptional silencing [18].
TRBP contains two double-stranded RNA binding
domains (RBD) [17] and was originally characterized
and cloned based on its high affinity binding to
the HIV-1 small hairpin leader RNA, TAR [19-21].
Consistent with the notion of miRNA-mediated restric-
tion of viral infection in mammalian cells, loss of TRBP
activity through its sequestration by TAR RNA resulted
in the enhanced replication of HIV-1 in human cells
[22]. To date, TRBP is considered to act inside cells
through at least three different mechanisms: it can pro-
mote the translation of TAR RNA-containing viral
RNAs [23]; it can directly bind and inhibit the interferon
(IFN)-induced double-stranded RNA (dsRNA)-activated
protein kinase R (PKR) [24]; and as mentioned above, it
can be a Dicer co-factor in the miRNA/siRNA RNAi
pathway. To gain additional insight into TRBP function,
we sought to identify human cellular factors that associ-
ate with TRBP. Here, using co-immunoprecipitation
(co-IP) and protein-identification by mass spectrometry,
we report proteins in a TRBP-proteome.
Figure 1A shows the Coomassie blue stained profile of
proteins that co-IP with TRBP. After treating with RNase
A, the majority (> 80%) of the co-IP products were reduced
in amounts, suggesting that many TRBP-interacting part-
ners in the co-IP are indirectly linked via RNA-association
(silver stain, Figure 1B). Next, we compared “Mock” to
“TRBP” samples based on silver staining; and we excised
the corresponding Coomassie blue stained protein bands
that were enhanced in the TRBP sample. These bands
were then analyzed by LC-MS/MS spectrometry (Figure
1A). The corresponding gel bands from the “Mock” sample
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any medium, provided the original work is properly cited.were also excised and analyzed in parallel. By subtracting
the “Mock” protein identification data from the “TRBP”
protein identification data, 160 “TRBP-associated” factors
were identified (Additional file 1, Table S1). The functional
relevance (according to the p value computed by the Inge-
nuity Systems algorithm using right-tailed Fisher Exact
Test) of each category of protein factors to established
pathways is diagrammed in Figure 2, and the protein iden-
tities present in each functional category are listed in
Table 1. Similar to a previous report [25], our results show
that TRBP is significantly associated with factors in the
protein synthesis machinery that is constituted by the 80S
ribosome [20 out of 32 proteins (RPSs; ribosomal protein,
small subunits) of the 40S ribosomal subunits, and 24 out
of 46 proteins (RPLs; ribosomal protein, large subunits) of
the 60S ribosomal subunit were identified] [26]. Also iden-
tified were several translation elongation factors (e.g.
ABCF1, EEF1A2, EIF2AK2 and EIF2S1) (Table 1).
Although previous reports implicated TRBP as active pri-
marily in the cytoplasm, our mass spectrometry results
(Additional file 2. Supplementary Materials and Methods)
identified several TRBP-interacting nuclear factors which
are known to participate in processes including RNA spli-
cing, cellular growth and proliferation and gene transcrip-
tion (Figure 2, Table 1; and Additional file 1, Table S1).
F o re x a m p l e ,E F T U D 2 ,H N R P C ,P R P F 8 ,P T B P 1 ,S F R S 1 ,
SYNCRIP, SNRPD1, SNRPD3 and U2AF1 are components
of the small nuclear ribonucleoprotein (snRNPs) that are
involved in splicing of pre-mRNAs. Related to gene tran-
scription, TRBP-associated proteins include those found
Figure 1 Gel electrophoresis profile of the TRBP-interacting proteins. (A) Total cell lysates from HeLa cells overexpressing Flag-TRBP were
collected and immunoprecipitated with monoclonal anti-Flag agarose. Flag-TRBP and its interacting proteins were eluted with 3X Flag
polypeptides and were subjected to sodium dodecyl-sulfate (SDS) gel electrophoresis followed by colloidal Coomassie staining.
Co-immunoprecipitated products using cell lysates with mock transfection were compared. Fifteen gel bands as marked from the mock and
TRBP eluents were excised for mass spectrometry analyses. (B) The immunoprecipitated Flag-agarose beads were treated with RNase A for 1
hour and washed three times with RIPA buffer. The remaining binding proteins were eluted with 3X Flag polypeptides and analyzed by gel-
electrophoresis and silver staining. Please see Additional file 2, supplementary Materials and Methods, for detailed methodology.
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transcription (Additional file 1, Table S1). Additionally, a
TRBP-associated factor, Sox21, is a HMG-box transcrip-
tion factor that acts in a complex array of repressive and
activating transcriptional processes in embryonic stem
cells [27]. The transcription co-activator HMGA1 was also
identified in our proteomic data (Table 1). Whether TRBP
participates in the determination of pluripotency through
Sox21 requires further study.
Recently, TRBP truncating mutations were found in
human cancers with microsatellite instability [28]. Evi-
dence exists which supports the notion that impaired
Figure 2 Functional categorization of the TRBP-interacting proteins. Categorization of the molecular function of the 160 TRBP interacting
proteins was done using the Ingenuity Pathway Analysis software. The y-axis shows statistical relevance of the TRBP-interacting factors in the
indicated functional categories. The protein identities of TRBP-associated factors in each functional category are summarized in Table 1.
Table 1 Functional categories of the TRBP-associated complex
Category Molecules
Protein Synthesis ABCF1, EEF1A2, EIF2AK2, EIF2S1, PTBP1, RPL3, RPL4, RPL5, RPL6, RPL7, RPL9, RPL11, RPL15,
RPL18, RPL21, RPL22, RPL24, RPL30, RPL32, RPL34, RPL35, RPL18A, RPL23A, RPL27A, RPL29
(includes EG:6159), RPL31 (includes EG:6160), RPL7A (includes EG:6130), RPS2, RPS5, RPS6, RPS9,
RPS10, RPS11, RPS17 (includes EG:6218), RPS3A
RNA Post-Transcriptional Modification DDX17, DDX54, EFTUD2, HNRPAB, HNRPC, HNRPUL1, PABPC1, PRPF8, PTBP1, SFRS1, SNRPD1,
SNRPD3, SYNCRIP, U2AF1
Cellular Growth and Proliferation AKAP13, ATP5B, ATP5F1, CCT2, DBN1, DCD, DNAJA3, EIF2AK2, GLTSCR2, HMGA1, HNRPA1,
HNRPAB, HNRPC, HNRPF, HNRPM, PHB (includes EG:5245), PPP1R9B, PRPF8, PRPF19, RAP1B,
RPS3A, RSL1D1, SART1, SFRS1, TOP1, XRN2
Gene Expression BASP1, BTF3, CDC5L, CHD4, CSDA, DDX5, DEK, EIF2S1, GTF3C1, GTF3C3, GTF3C4, HMGA1,
HNRPAB, IGHMBP2, PARP1, PHB (includes EG:5245), RBM39, RPL6, SOX21, TARBP2, TOP1, TOP2A
Cell Death DDX5, DIDO1, DNAJA3, EEF1A2, EIF2AK2, EIF2S1, GNL3, HIST1H1C, HMGA1, HNRPA1, HNRPC,
HSPA1B, PARP1, PHB (includes EG:5245), PPP1R9B, PRPF19, RBBP4, RPLP0 (includes EG:6175),
RPS3A, SLC2A1, TOP1, TOP2A
DNA Replication, Recombination, and Repair CDC5L, HMGA1, HSPA1B, IGHMBP2, PARP1, PRPF19, TOP1, TOP2A
Cell Cycle CDC5L, EIF2AK2, GNL3, HMGA1, NOL1, PARP1, PES1, PHB (includes EG:5245), PPP1R9B, PRMT5,
RPL5, RPL11, RPL23, TOP2A
Cancer RPL5, RPL11, RPL23, AKAP13, ASPH, DNAJA3, HMGA1, HSPA1B, PES1, PRMT5, RPS3A
Skeletal and Muscular Disorders RPL5, RPL11, RPL23
Cell Morphology AKAP13, ASPH, DNAJA3, HMGA1, HSPA1B, PES1, PRMT5, RPS3A
Cellular Function and Maintenance/Connective
Tissue Development and Function
EIF2AK2, EIF2S1
Viral Function AKAP13, EIF2AK2, HMGA1, PARP1, SFRS1
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protein are correlated with tumorigenesis [28]. Because
TRBP is known to interact with Dicer and to be
involved in mRNA processing, how TRBP and TRBP-
interacting proteins contribute to oncogenesis merits
future investigation. The current TRBP proteome pro-
vides a starting point for initiating those explorations.
Our study describes the TRBP-proteome in HeLa cells.
Although TRBP was originally identified as the HIV-1
TAR RNA-binding protein, its more recently character-
ized function in microRNA biogenesis and RISC-activity
is widely conserved in all cell types (e.g. epithelial,
hematopoietic, mesenchymal cells etc...). Thus, a HeLa-
l i k eT R B P - p r o t e o m ei sl i k e l yt ob ef o u n di na l lt y p e so f
human cells. We realize that systematic functional vali-
dation of the currently identified TRBP proteome will
be necessary in order to clarify the biological relevance
of each factor. Indeed, some of the TRBP-interacting
proteins are being currently characterized.
Additional material
Additional file 1: Supplementary Table S1. Pubmed ID, gene name,
functional description, hits in proteomics study and alternative symbol
for TRBP-interacting factors.
Additional file 2: Supplementary Materials and Methods.
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